ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 160 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $655,077 | -74.7% | 4,970,232 | -2.0% | 0.00% | – |
| Q2 2023 | $2,586,914 | -19.3% | 5,072,380 | -0.3% | 0.00% | – |
| Q1 2023 | $3,205,219 | -9.1% | 5,087,649 | -6.4% | 0.00% | – |
| Q4 2022 | $3,526,778 | -60.5% | 5,433,334 | +4.7% | 0.00% | – |
| Q3 2022 | $8,927,000 | +37.4% | 5,190,042 | -0.9% | 0.00% | – |
| Q2 2022 | $6,495,000 | -40.4% | 5,237,799 | -68.6% | 0.00% | – |
| Q1 2022 | $10,898,000 | -40.4% | 16,704,707 | -0.4% | 0.00% | – |
| Q4 2021 | $18,275,000 | -40.7% | 16,764,972 | -1.0% | 0.00% | -100.0% |
| Q3 2021 | $30,822,000 | -28.8% | 16,935,724 | +3.3% | 0.00% | 0.0% |
| Q2 2021 | $43,277,000 | -35.6% | 16,392,190 | -12.2% | 0.00% | -50.0% |
| Q1 2021 | $67,239,000 | +43.8% | 18,677,205 | +0.6% | 0.00% | +100.0% |
| Q4 2020 | $46,771,000 | +23.9% | 18,560,333 | +23.9% | 0.00% | 0.0% |
| Q3 2020 | $37,762,000 | -25.0% | 14,985,065 | -2.3% | 0.00% | -50.0% |
| Q2 2020 | $50,322,000 | +47.3% | 15,341,526 | +10.0% | 0.00% | 0.0% |
| Q1 2020 | $34,165,000 | -42.1% | 13,945,014 | +11.6% | 0.00% | 0.0% |
| Q4 2019 | $58,962,000 | +12.2% | 12,491,719 | +1.7% | 0.00% | 0.0% |
| Q3 2019 | $52,573,000 | -23.3% | 12,283,844 | +4.5% | 0.00% | -33.3% |
| Q2 2019 | $68,522,000 | +88.2% | 11,753,413 | +24.3% | 0.00% | +50.0% |
| Q1 2019 | $36,416,000 | +109.7% | 9,458,915 | +1.8% | 0.00% | +100.0% |
| Q4 2018 | $17,369,000 | -41.6% | 9,288,084 | -0.0% | 0.00% | 0.0% |
| Q3 2018 | $29,727,000 | +7.4% | 9,289,620 | +1.3% | 0.00% | 0.0% |
| Q2 2018 | $27,686,000 | -16.4% | 9,167,740 | +8.5% | 0.00% | -50.0% |
| Q1 2018 | $33,124,000 | -5.9% | 8,449,936 | -0.6% | 0.00% | 0.0% |
| Q4 2017 | $35,187,000 | -30.3% | 8,499,209 | +3.4% | 0.00% | -33.3% |
| Q3 2017 | $50,466,000 | +4.5% | 8,219,206 | +5.9% | 0.00% | 0.0% |
| Q2 2017 | $48,280,000 | +1.0% | 7,762,076 | +2.9% | 0.00% | 0.0% |
| Q1 2017 | $47,821,000 | +82350.0% | 7,542,908 | +69664.2% | 0.00% | – |
| Q4 2016 | $58,000 | -14.7% | 10,812 | -10.8% | 0.00% | – |
| Q3 2016 | $68,000 | +1.5% | 12,118 | -2.4% | 0.00% | – |
| Q2 2016 | $67,000 | 0.0% | 12,414 | +38.5% | 0.00% | – |
| Q1 2016 | $67,000 | +28.8% | 8,966 | +40.6% | 0.00% | – |
| Q4 2015 | $52,000 | +188.9% | 6,375 | +216.7% | 0.00% | – |
| Q3 2015 | $18,000 | -40.0% | 2,013 | -21.7% | 0.00% | – |
| Q2 2015 | $30,000 | +15.4% | 2,570 | +7.8% | 0.00% | – |
| Q1 2015 | $26,000 | +116.7% | 2,384 | 0.0% | 0.00% | – |
| Q4 2014 | $12,000 | +71.4% | 2,384 | -12.9% | 0.00% | – |
| Q3 2014 | $7,000 | -22.2% | 2,738 | +29.4% | 0.00% | – |
| Q2 2014 | $9,000 | -10.0% | 2,116 | -2.9% | 0.00% | – |
| Q1 2014 | $10,000 | +25.0% | 2,179 | +16.0% | 0.00% | – |
| Q4 2013 | $8,000 | +14.3% | 1,879 | 0.0% | 0.00% | – |
| Q3 2013 | $7,000 | – | 1,879 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
| MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
| MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
| CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
| MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
| Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
| Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
| Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |